We report the case of a Nigerian adolescent recently arrived to Spain, who presented at the emergency room with severe respiratory distress. She had been previously diagnosed of HIV-1 discontinuing antiretroviral therapy, what was hidden by the family. This case illustrates the difficulties in management and stigma in HIV-infected adolescents, particularly immigrants and the need to collect all the information available before starting antiretroviral therapy.
References
[1]
United Nations Children’s Fund/World Health Organization (UNAIDS/WHO), “Status of the Global HIV Epidemic,” Report on the Global AIDS Epidemic, 2008.
[2]
E. Nú?ez Cuadros, M. J. Mellado Pe?a, M. Rivera Cuello, M. Penim Fernández, R. Pi?eiro Pérez, M. García- Hortelano, M. J. Cilleruelo Ortega, J. Villota Arrieta and P. Martín-Fontelos, “Antiretroviral Drug Toxicity in Human Immunodeficiency Virus Infected Children,” An Pediatr (Barc), Vol. 68, No. 5, 2008, pp. 425-431.
[3]
PENTA Steering Committee, “PENTA 2009 Guidelines for the Use of Antiretroviral Therapy in Paediatric HIV-1 Infection,” HIV Medicine, Vol. 10, No. 10, 2009, pp. 591- 613. doi:10.1111/j.1468-1293.2009.00759.x
[4]
Centers for Disease Control and Prevention, “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection,” 2010, pp. 1-219.
http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf
[5]
R. B. Van Dyke, S. Lee and G. M. Johnson, “Reported Adherence as a Determinant of Response to Highly Active Antiretroviral Therapy in Children Who Have Human Immunodeficiency Virus Infection,” Pediatrics, Vol. 109, No. 4, 2002, p. 61.
doi:10.1542/peds.109.4.e61
[6]
B. Brichard and D. Van der Linden, “Clinical Practice Treatment of HIV Infection in Children,” European Journal of Pediatrics, Vol. 168, No. 4, 2009, pp. 387-392.
doi:10.1007/s00431-008-0914-8
[7]
D. A. Murphy, M. Sarr, S. J. Durako, A. B. Moscicki, C. M. Wilson and L. R. Muenz, “Adolescent Medicine HIV/AIDS Research Network. Barriers to HAART Adherence among Human Immunodeficiency Virus-Infected Adolescents,” Archives of Pediatrics & Adolescent Med- icine, Vol. 157, No. 3, 2003, pp. 249-255.
[8]
D. Oshi, S. Nakalema and L. Oshi, “Cultural and Social Aspects of HIV/AIDS Sex Education in Secondary Schools in Nigeria,” Journal of Biosocial Science, Vol. 37, No. 2, 2005, pp. 175-183.
doi:10.1017/S0021932004006820
[9]
J. M. Wallace, N. I. Hansen and L. Lavange, “Respiratory Disease Trends in the Pulmonary Complications of HIV Infection Study Cohort,” American Journal of Respiratory and Critical Care Medicine, Vol. 155, No. 1, 1997, pp. 72-80.
[10]
K. Hewitt, R. Steketee, V. Mwapasa, J. Whitworth and N. French, “Interactions between HIV and Malaria in Non- pregnant Adults: Evidence and Implications,” AIDS, Vol. 20, No. 16, 2006, pp. 1993-2004.
doi:10.1097/01.aids.0000247572.95880.92
[11]
J. Mermin, J. R. Lule and J. P. Ekwaru, “Association between Malaria and CD4 Cell Count Decline among Persons with HIV,” Journal of Acquired Immune Deficiency Syndromes, Vol. 41, No. 1, 2006, pp. 129-130.
doi:10.1097/01.qai.0000179427.11789.a7
[12]
M. D. Herrero, P. Rivas, N. I. Rallón, G. Ramírez-Oli- vencia and S. Puente, “HIV and Malaria,” AIDS Reviews, Vol. 9, 2007, pp. 88-98.
